Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Archives for Nerac Insights / Articles

Vanishing Packaging: A Tech Scouting Report

By Rosemarie Szostak, Ph.D., Nerac Analyst
Originally published January 20, 2017
This sample report demonstrates technology scouting in the edible packaging market space.
Read More

The Regulatory Environment for 3D Printing in the Healthcare Field

By Erica Kramer,Ph.D., Nerac Analyst
Originally published January 19, 2017
Learn more about 3D printing in the medical field and and key conclusions on regulatory issues in the healthcare market.
Read More

Don’t Be Afraid — How to Quickly and Thoroughly Review a Patent

By Kevin Closson, M.A., Nerac Analyst
Originally published January 19, 2017
An overview of the most important elements of reviewing a patent.
Read More

Exciting Novel, but High-Cost Developments in Cancer Treatment: Immunotherapy continues to advance as a validated approach

By Holly Magna, Ph.D., Nerac Analyst
Originally published November 28, 2016
A review of some of the newly marketed therapies and some still in development, as well as their complications, risks and advantages
Read More

Graphene: Quest for the Killer App

By Rosemarie Szostak, Ph.D., Nerac Analyst
Originally published November 28, 2016
The hunt for the killer app for graphene is on!
Read More

Drug Safety Updates – Regulations and FDA Guidance for Industry

By Stephen Buxser, Ph.D., Nerac Analyst
Originally published November 28, 2016
For drugs licensed for sale in the United States, as well as elsewhere in the world, there are requirements for periodic literature updates/reviews. This article describes the legal requirements for drug safety and efficacy reporting.
Read More

Defining “Natural” in Food Labeling – Why does it matter?

By Helga Weires, Nerac Analyst
Originally published October 13, 2016
Defining the term “natural” has been a hot topic among the manufacturers, consumers and regulators of the food industry in recent years. The use of the term “natural” or “all natural” is ubiquitous on store shelves across the country, yet there has been confusion as to what this word really means in food labeling and advertising.
Read More

Patent Landscaping and Mount Everest: How to navigate a successful trip

By Tom Perkins, Nerac Analyst
Originally published October 13, 2016
This article compares some similarities to preparing and creating a successful patent portfolio using patent landscaping with reaching the summit of the world’s tallest peak.
Read More

Brexit: Implications on your Intellectual Property Rights

By Eden Joy Pacsial-Ong, Ph.D.
Originally published October 13, 2016
This article reviews some of the impacts of the British exit from EU, or Brexit, and the resulting uncertainty that surrounds the UK, its relationship with the EU, and the ultimate impact on trade, immigration and intellectual property (IP) laws.
Read More

Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A 3-Part Nerac Perspective

By Richard Conforti, M.S.
Originally published August 15, 2016
This is a 3-part series of articles on the 2014 Chinese Food and Drug Administration(CFDA), providing an update on their medical device regulations. The first article discussed which devices can be used to support your submission to the CFDA. The second article addressed the changes to selecting clinical literature. The third article describes the final clinical literature report.
Read all three here

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 20
  • Next Page »
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2022 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.